Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy
Background Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2-3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC prog...
主要な著者: | Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2014
|
類似資料
-
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
著者:: Rajan, P, 等
出版事項: (2014) -
Sequencing depth and coverage: key considerations in genomic analyses.
著者:: Sims, D, 等
出版事項: (2014) -
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
著者:: Shtutman Michael, 等
出版事項: (2010-04-01) -
The early effects of rapid androgen deprivation on human prostate cancer
著者:: Shaw, G, 等
出版事項: (2015) -
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
著者:: Justin H. Hwang, 等
出版事項: (2019-11-01)